Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells

被引:171
作者
Yang, FC
Ingram, DA
Chen, S
Hingtgen, CM
Ratner, N
Monk, KR
Clegg, T
White, H
Mead, L
Wenning, MJ
Williams, DA
Kapur, R
Atkinson, SJ
Clapp, DW
机构
[1] Indiana Univ, Sch Med, Canc Res Inst, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Neurol & Pharmacol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[4] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
[5] Indiana Univ, Sch Med, Dept Neurol & Pharmacol, Indianapolis, IN 46202 USA
[6] Indiana Univ, Sch Med, Dept Cell Biol, Indianapolis, IN 46202 USA
[7] Univ Cincinnati, Coll Med, Dept Neurobiol & Anat, Cincinnati, OH USA
[8] Cincinnati Childrens Hosp, Ctr Med, Div Expt Hematol, Cincinnati, OH USA
[9] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA
关键词
D O I
10.1172/JCI200319195
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The NF1 tumor suppressor gene encodes a GTPase-activating protein called neurofibromin that negatively regulates Ras signaling. Mutations in NF1 cause neurofibromatosis type 1 (NF1). The development of neurofibromas, which are complex tumors composed of multiple cell types, is a hallmark of NF1. Somatic inactivation of murine Nf1 in Schwann cells is necessary, but not sufficient, to initiate neurofibroma formation. Neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1(+/-)) microenvironment. Mast cells infiltrate neurofibromas, where they secrete proteins that can remodel the ECM and initiate angiogenesis. Thus, identification of mechanisms responsible for mast cell migration to tumor microenvironments is important for understanding tumorigenesis and for designing potential therapies. Here, we show that homozygous Nf1 mutant (Nf1(-/-)) Schwann cells secrete Kit ligand (KitL), which stimulates mast cell migration, and that Nf1(+/-) mast cells are hypermotile in response to KitL. Furthermore, we link hyperactivation of the Ras-class I-A-PI3K-Rac2 pathway to increased Nf1(+/-) mast cell migration. Thus, these studies identify a novel interaction between Nf1(-/-) Schwann cells and Nf1(+/-) mast cells that is likely to be important in neurofibroma formation.
引用
收藏
页码:1851 / 1861
页数:11
相关论文
共 50 条
[41]   Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator [J].
Lappalainen, H ;
Laine, P ;
Pentikäinen, MO ;
Sajantila, A ;
Kovanen, PT .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) :1880-1885
[42]   Comprehensive NF1 screening on cultured Schwann cells from neurofibromas [J].
Maertens, Ophelia ;
Brems, Hilde ;
Vandesompele, Jo ;
De Raedt, Thomas ;
Heyns, Ine ;
Rosenbaum, Thorsten ;
De Schepper, Sofie ;
De Paepe, Anne ;
Mortier, Geert ;
Janssens, Sandra ;
Speleman, Frank ;
Legius, Eric ;
Messiaen, Ludwine .
HUMAN MUTATION, 2006, 27 (10) :1030-1040
[43]   Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells [J].
Petrilli, Alejandra M. ;
Garcia, Jeanine ;
Bott, Marga ;
Plati, Stephani Klingeman ;
Dinh, Christine T. ;
Bracho, Olena R. ;
Yan, Denise ;
Zou, Bing ;
Mittal, Rahul ;
Telischi, Fred F. ;
Liu, Xue-Zhong ;
Chang, Long-Sheng ;
Welling, D. Bradley ;
Copik, Alicja J. ;
Fernandez-Valle, Cristina .
ONCOTARGET, 2017, 8 (19) :31666-31681
[44]   Stimulus strength determines the BTK-dependence of the SHIP1-deficient phenotype in IgE/antigen-triggered mast cells [J].
Carolin N. Zorn ;
Anne Simonowski ;
Michael Huber .
Scientific Reports, 8
[45]   Stimulus strength determines the BTK-dependence of the SHIP1-deficient phenotype in IgE/antigen-triggered mast cells [J].
Zorn, Carolin N. ;
Simonowski, Anne ;
Huber, Michael .
SCIENTIFIC REPORTS, 2018, 8
[46]   NF1+/- Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response [J].
Dodd, Rebecca D. ;
Lee, Chang-Lung ;
Overton, Tess ;
Huang, Wesley ;
Eward, William C. ;
Luo, Lixia ;
Ma, Yan ;
Ingram, Davis R. ;
Torres, Keila E. ;
Cardona, Diana M. ;
Lazar, Alexander J. ;
Kirsch, David G. .
CANCER RESEARCH, 2017, 77 (16) :4486-4497
[47]   Susceptible Stages in Schwann Cells for NF1-Associated Plexiform Neurofibroma Development [J].
Le, Lu Q. ;
Liu, Chiachi ;
Shipman, Tracey ;
Chen, Zhiguo ;
Suter, Ueli ;
Parada, Luis F. .
CANCER RESEARCH, 2011, 71 (13) :4686-4695
[48]   Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism [J].
Fay, Christian X. ;
Zunica, Elizabeth R. M. ;
Awad, Elias ;
Bradley, William ;
Church, Cameron ;
Liu, Jian ;
Liu, Hui ;
Crossman, David K. ;
Mobley, James A. ;
Kirwan, John P. ;
Axelrod, Christopher L. ;
Westin, Erik ;
Kesterson, Robert A. ;
Wallis, Deeann .
SCIENTIFIC REPORTS, 2025, 15 (01)
[49]   JNK inhibitors increase osteogenesis in Nf1-deficient cells [J].
Sullivan, Kate ;
El-Hoss, Jad ;
Little, David G. ;
Schindeler, Aaron .
BONE, 2011, 49 (06) :1311-1316
[50]   Regulation of the viability of Nf1 deficient cells by PKC isoforms [J].
Zhou, Xiaodong ;
Shen, Ling ;
Parris, Toshima ;
Huang, Junchi ;
Yi, Bo ;
Helou, Khalil ;
Chen, Changyan .
ONCOTARGET, 2014, 5 (21) :10709-10717